Gulf International Bank (UK)’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-7,200
Closed -$970K – 697
2022
Q3
$970K Hold
7,200
– – 0.02% 570
2022
Q2
$1.17M Hold
7,200
– – 0.02% 561
2022
Q1
$1.36M Hold
7,200
– – 0.02% 558
2021
Q4
$1.95M Buy
7,200
+1,200
+20% +$405K 0.03% 511
2021
Q3
$2.18M Hold
6,000
– – 0.03% 528
2021
Q2
$2.06M Hold
6,000
– – 0.03% 554
2021
Q1
$2.09M Hold
6,000
– – 0.03% 531
2020
Q4
$1.55M Sell
6,000
-3,900
-39% -$1.07M 0.02% 606
2020
Q3
$2.83M Buy
9,900
+1,000
+11% +$235K 0.04% 410
2020
Q2
$1.68M Hold
8,900
– – 0.03% 522
2020
Q1
$1.09M Hold
8,900
– – 0.02% 539
2019
Q4
$1.48M Hold
8,900
– – 0.02% 568
2019
Q3
$1.09M Hold
8,900
– – 0.02% 586
2019
Q2
$1.1M Hold
8,900
– – 0.02% 598
2019
Q1
$1.17M Hold
8,900
– – 0.02% 574
2018
Q4
$1.25M Buy
+8,900
New +$1.18M 0.02% 543

Other funds holding ONC

Gulf International Bank (UK)'s ONC Position: Q4 2022 in Review

Gulf International Bank (UK) sold out of BeOne Medicines Ltd (ONC) in Q4 2022, closing a stake of 7,200 shares — an estimated $970K sold.

Gulf International Bank (UK) first reported a position in ONC in Q4 2018 and held it in 16 quarters. The position peaked at $2.83M in Q3 2020. 212 funds tracked by Wall St. Rank hold ONC as of Q4 2022.

  • Gulf International Bank (UK) reported no remaining BeOne Medicines Ltd position as of Q4 2022 after selling out during the quarter.
  • Gulf International Bank (UK) sold 7,200 BeOne Medicines Ltd shares in Q4 2022, an estimated $970K.
  • Gulf International Bank (UK) first reported a position in BeOne Medicines Ltd in Q4 2018 and held it in 16 quarters.
  • Gulf International Bank (UK)'s BeOne Medicines Ltd position peaked at $2.83M in Q3 2020.
  • 212 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q4 2022.

Based on Gulf International Bank (UK)'s 13F filing for Q4 2022, filed 8 Feb 2023.